Tetraphase Pharmaceu
(TTPH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2015 | 12-2014 | 09-2014 | 06-2014 | 03-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -20,986 | -66,742 | -46,191 | -31,986 | -13,523 |
| Depreciation Amortization | 125 | 350 | 277 | 185 | 95 |
| Accounts receivable | -2,021 | -1,752 | -247 | 363 | -311 |
| Accounts payable and accrued liabilities | 1,405 | 2,224 | 1,856 | 4,843 | 2,044 |
| Other Working Capital | -1,742 | 3,422 | 162 | 4,999 | -117 |
| Other Operating Activity | 3,503 | 4,875 | 1,873 | -2,930 | -555 |
| Operating Cash Flow | $-19,716 | $-57,623 | $-42,270 | $-24,526 | $-12,367 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -51 | -191 | -172 | -56 | -29 |
| Investing Cash Flow | $-51 | $-191 | $-172 | $-56 | $-29 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -4,646 | -6,126 | -4,746 | -3,126 | -1,545 |
| Common Stock Issued | 163,691 | 82,270 | 473 | 367 | 240 |
| Financing Cash Flow | $159,045 | $76,144 | $-4,273 | $-2,759 | $-1,305 |
| Beginning Cash Position | 121,042 | 102,712 | 102,712 | 102,712 | 102,712 |
| End Cash Position | 260,320 | 121,042 | 55,997 | 75,371 | 89,011 |
| Net Cash Flow | $139,278 | $18,330 | $-46,715 | $-27,341 | $-13,701 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,716 | -57,623 | -42,270 | -24,526 | -12,367 |
| Capital Expenditure | -51 | -191 | -172 | -56 | -29 |
| Free Cash Flow | -19,767 | -57,814 | -42,442 | -24,582 | -12,396 |